Intellia Therapeutics is based in Cambridge, Massachusetts. It has raised $197M in total funding. Latest round: IPO.
Intellia Therapeutics funding overview
Intellia Therapeutics is based in Cambridge, Massachusetts. Intellia Therapeutics has raised $197M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in January 2016. The round record for Intellia Therapeutics runs through 2016; nothing later has been disclosed.
Intellia Therapeutics at a glance
Total raised
$197M
Latest round
IPO
Latest round date
January 2016
Headquarters
Cambridge, Massachusetts
Frequently asked about Intellia Therapeutics funding
How much has Intellia Therapeutics raised?
Intellia Therapeutics has raised $197M in total disclosed funding across the rounds on record.
Who has invested in Intellia Therapeutics?
No investors are named on the public record for Intellia Therapeutics yet.
What was the latest Intellia Therapeutics funding round?
The most recent disclosed round is an IPO, announced in January 2016.
Where is Intellia Therapeutics based?
Intellia Therapeutics is based in Cambridge, Massachusetts.
When did Intellia Therapeutics last raise?
The last disclosed Intellia Therapeutics round closed in January 2016 at IPO.
Totals shown for Intellia Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
